Adjunctive Transdermal Cannabidiol for Adults With Focal Epilepsy
While adjunctive transdermal cannabidiol (ZYN002) at doses of 195 mg or 390 mg daily did not demonstrate statistically significant superiority over.
CED Clinic
Medicinal cannabis is changing the face of clinical medicine. We are the leaders of that change.
CED Clinic
Medicinal cannabis is changing the face of clinical medicine. We are the leaders of that change.
Physician-reviewed summaries of published studies and answered patient questions that name Epilepsy. Every study linked here carries a PubMed identifier that was checked against PubMed.
Before you go
A one-page guide from Dr. Caplan, corrected with the latest published measurements. It is sent to your inbox when you join the newsletter.
Join the growing cannabis community and get new research explained in plain language, so you never miss the studies that matter.
Free. Unsubscribe anytime with one click.
Your privacy choices. We use essential cookies to run this site. With your permission we also use analytics cookies to see which pages help readers.